Skip to main content
. 2016 Jul 11;24:18. doi: 10.1186/s40199-016-0156-7

Fig. 7.

Fig. 7

Comparison of platelet counts (103/μl) between recombinant Romiplostim Injected Group and Control Group on days 0, 4, 7 and 17. On day 0 Recombinant Romiplostim (50 μg/kg) and normal saline (0.2 mL/mice) were subcutaneously injected into case and control groups, respectively. Mean platelet counts were assayed on days 0, 4, 7, 17 through preorbital sinus sampling. As it is shown in the recombinant Romiplostim treated group, platelet value has increased nearly more than 2 folds to the control group on day 4, and it returned to day 0 level on day 17. Error bar (95 % CI): Platelet counts in 10 BALB/c mice in each case and control group